The Other Silent Disease: Osteoporosis
-
Register
- User - $30
This session will focus on identification of the at risk patient for osteoporosis. Most recent treatments will be discussed in detail.
Credits: 1.0 Contact Hours; 0.58 are Pharmacology
Expiration Date: December 31st, 2025
$30
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
- As a result of this activity the participant will be able to Identify the risk factors for sustaining a fragility fracture
-Understand the pharmacologic and non-pharmacological treatments for osteoporosis beyond just bisphosphonates
-As a result of this activity the learner will apply learned knowledge to case studies related to patients with osteoporosis
Dr. Christopher Hemmer, DNP, ANP, ONP-C, FAANP
ANP, Piper Spine Care
Assistant Professor, Saint Louis University School of Nursing
Dr. Hemmer has been board certified as an adult nurse practitioner since 1999. He is also a board-certified orthopedic nurse practitioner and a fellow of the American Association of nurse practitioners. His area of specialty is in adult spinal disorders for the last 22 years. He currently evaluates new patients as well as established pre and post-operative patients. Chris has spent over nine years moonlighting in the emergency department in the past as well.
Dr. Hemmer started teaching as an adjunct for Saint Louis University in 2007. In the fall of 2013, Christopher accepted a full-time position with the school of nursing as an assistant professor for graduate students. He has co-taught several graduate-level courses over the years as well as performed as a guest lecturer during residency for the NP students. Chris has been receptive for several years to teaching in the clinical setting as a preceptor for NP students interested in spinal diseases and wanting to increase their radiology knowledge. Dr. Hemmer chairs a cadaveric CNE course yearly for spine specialists. Chris has presented various spine topics on the local, state, and national level over the years.
Dr. Hemmer research area is in vertebral compression fractures and osteoporosis. Specifically, the identification and management of fractures and osteoporosis in the adult population is a strong area of interest.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.58 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Chris Hemmer, DNP, ANP, ONP-C, FAANP, FNAON have disclosed have disclosed no financial relationship.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
